RQ-PCR based WT1 expression in comparison to BCR-ABL quantification can predict Philadelphia negative clonal evolution in patients with imatinib-treated chronic myeloid leukaemia.

Source:http://linkedlifedata.com/resource/pubmed/id/19624538

Download in:

View as

General Info

PMID
19624538